Jianling Du
Dalian Medical University(CN)First Affiliated Hospital of Dalian Medical University(CN)
Publications by Year
Research Areas
Thyroid Disorders and Treatments, Thyroid Cancer Diagnosis and Treatment, Diabetes Treatment and Management, Metabolism, Diabetes, and Cancer, Diabetes, Cardiovascular Risks, and Lipoproteins
Most-Cited Works
- → Association ofTERTPromoter Mutation 1,295,228 C>T WithBRAFV600E Mutation, Older Patient Age, and Distant Metastasis in Anaplastic Thyroid Cancer(2015)89 cited
- → Hyperthyroidism Prevalence in China After Universal Salt Iodization(2021)36 cited
- → The efficacy and safety of iGlarLixi versus IDegAsp in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The Soli‐D randomized controlled trial(2024)14 cited
- → U-Shaped Associations between Urinary Iodine Concentration and the Prevalence of Metabolic Disorders: A Cross-Sectional Study(2019)2 cited
- → Efficacy and Safety of Long-Term Universal Salt Iodization on Thyroid Disorders: An Epidemiological Evidence from 31 Provinces of Mainland China(2019)1 cited
- → The Highest Prevalence of Diabetes Recorded in Mainland China: A National Epidemiologic Survey(2019)1 cited
- → 1869-LB: Efficacy and Safety of iGlarLixi vs. IDegAsp in Chinese People with Type 2 Diabetes (T2D) Suboptimally Controlled with Oral Antidiabetic Drug(s) (OAD)—The SoliD Randomized Controlled Trial(2024)
- → The analysis of the changes of maternal thyroid autoantibodies during early pregnancy(2016)
- → The Status of Iodine Nutrition and Thyroid Disorders in China: Two Decades After the Universal Salt Iodization(2018)
- → Author response for "The efficacy and safety of <scp>iGlarLixi</scp> versus <scp>IDegAsp</scp> in <scp>Chinese</scp> people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The <scp>Soli‐D</scp> randomized controlled trial"(2024)